V. Estrella

发表

Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling

K. Rejniak, A. Karolak, D. Morse, 2018, Scientific Reports.

Acidity generated by the tumor microenvironment drives local invasion.

Robert J Gillies, Robert A Gatenby, Yoganand Balagurunathan, 2013, Cancer research.

Multiscale Modelling of Vascular Tumour Growth in 3D: The Roles of Domain Size and Boundary Conditions

Robert J. Gillies, Helen M. Byrne, Robert A. Gatenby, 2011, PloS one.

Acidosis and cancer: from mechanism to neutralization

V. Estrella, Arig Ibrahim-Hashim, 2019, Cancer and Metastasis Reviews.

A physical sciences network characterization of non-tumorigenic and metastatic cells

Christopher S. Poultney, Casey M. Kraning-Rush, Cynthia A. Reinhart-King, 2013, Scientific Reports.

Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.

G. Mills, F. Claret, J. Wiener, 2007, International journal of oncology.

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

V. Sondak, A. Silva, K. Smalley, 2013, Molecular pharmaceutics.

Tumor Targeting, Pharmacokinetics and Biodistribution of a Near Infrared Fluorescent-labeled δ -Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5

D. Morse, J. Vagner, V. Estrella, 2016 .

3D Multiscale Modelling of Angiogenesis and Vascular Tumour Growth

P. Maini, R. Gillies, M. Owen, 2013 .

RAPID COMMUNICATION Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers 1

G. Mills, P. Thall, J. Wiener, 2003 .

Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer

G. Mills, M. Mao, R. Lapushin, 2000, Annals of the New York Academy of Sciences.

The Role of Tumor Tissue Architecture in Treatment Penetration and Efficacy: An Integrative Study

Katarzyna A. Rejniak, Tingan Chen, K. Rejniak, 2013, Front. Oncol..

Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.

D. Klumpp, V. Estrella, A. Gousse, 2006, The Journal of urology.

Acidosis and cancer: from mechanism to neutralization

V. Estrella, Arig Ibrahim-Hashim, 2019, Cancer and Metastasis Reviews.

Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.

M. Kramer, V. Estrella, V. Lokeshwar, 2008, Cancer research.

T-cells produce acidic niches in lymph nodes to suppress their own effector functions

R. Gillies, Hao Wu, A. Moshnikova, 2020, Nature Communications.

Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane

R. Gillies, R. Gatenby, M. Bui, 2015, Nature Communications.

Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers.

Peter F Thall, Gordon B Mills, Michael T Deavers, 2003, Gynecologic oncology.

In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes

R. Gillies, K. Gage, M. Budzevich, 2019, PloS one.

Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells

K. Bhalla, F. Lee, V. Richon, 2006, Clinical Cancer Research.

Cotreatment withVorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate^Sensitive or Imatinib Mesylate^Resistant Chronic Myelogenous Leukemia Cells

K. Bhalla, F. Lee, V. Richon, 2006 .

Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.

G. Mills, R. Bast, M. Mao, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lymph Nodes Inhibit T-cell Effector Functions Locally by Establishing Acidic Niches

R. Gillies, Y. Reshetnyak, P. Enriquez-Navas, 2019, bioRxiv.

Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling

K. Rejniak, A. Karolak, D. Morse, 2018, Scientific Reports.

HAS1 expression in bladder cancer and its relation to urinary HA test

Brian L. Cohen, S. Hautmann, M. Jordá, 2007, International journal of cancer.

Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.

V. Hruby, Jongphil Kim, D. Morse, 2016, Molecular pharmaceutics.

Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model.

Robert J Gillies, Robert A Gatenby, R. Gillies, 2011, Journal of cancer science & therapy.

Semiconducting Cu3BiS3 thin films formed by the solid-state reaction of CuS and bismuth thin films

P. K. Nair, V. Estrella, M. Nair, 2003 .

HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.

M. Soloway, M. Kramer, V. Estrella, 2006, Cancer research.

Crystalline structure of chemically deposited thallium sulfide thin films

P. K. Nair, V. Estrella, M. Nair, 2002 .

Intracellular Electric Field and pH Optimize Protein Localization and Movement

B. Frieden, R. Gillies, R. Gatenby, 2012, PloS one.

Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells

R. Gatenby, A. Berglund, S. Yoder, 2022, Cancer research.

L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor

R. Gillies, Jongphil Kim, V. Estrella, 2023, bioRxiv.

Chapter 3 3 D Multiscale Modelling of Angiogenesis and Vascular Tumour Growth

P. Maini, R. Gillies, M. Owen, 2012 .

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

V. Sondak, A. Silva, K. Smalley, 2013, Molecular Pharmaceutics.

Acidity suppresses T cell function and increases memory T cell development

P. Enriquez-Navas, Mehdi Damaghi, R. Gillies, 2019, The FASEB Journal.